SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-21-000027
Filing Date
2021-08-12
Accepted
2021-08-12 16:16:43
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20210630.htm   iXBRL 10-Q 954666
2 EX-31.1 sum-ex311_2021630x10q.htm EX-31.1 11497
3 EX-32.1 sum-ex321_2021630x10q.htm EX-32.1 6544
  Complete submission text file 0001599298-21-000027.txt   4271122

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20210630.xsd EX-101.SCH 35481
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20210630_cal.xml EX-101.CAL 46537
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20210630_def.xml EX-101.DEF 122706
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20210630_lab.xml EX-101.LAB 404439
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20210630_pre.xml EX-101.PRE 261498
9 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20210630_htm.xml XML 615322
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 211167798
SIC: 2834 Pharmaceutical Preparations